By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
    Health
    Healthcare organizations are operating on slimmer profit margins than ever. One report in August showed that they are even lower than the beginning of the…
    Show More
    Top News
    An Expert’s Guide To Building and Improving Endurance
    June 30, 2022
    medical assistants
    What Do Medical Assistants Do On a Day to Day Basis?
    April 5, 2022
    superfoods to help with prostate health
    10 Healthy Foods That Can Help Protect Your Prostate
    August 29, 2022
    Latest News
    Why Custom Telemedicine Apps Outperform Off‑the‑Shelf Solutions
    July 20, 2025
    How Probate Planning Shapes the Future of Your Estate and Family Care
    July 17, 2025
    Beyond Nutrition: Everyday Foods That Support Whole-Body Health
    June 15, 2025
    The Wide-Ranging Benefits of Magnesium Supplements
    June 11, 2025
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
    Policy and Law
    Get the latest updates about Insurance policies and Laws in the Healthcare industry for different geographical locations.
    Show More
    Top News
    How Powerful Patients Save the System Money
    November 11, 2015
    How Financial Barriers are Slowing Down Telehealth Adoption
    September 26, 2017
    No Resource Constraints in Dialysis: a Blessing and a Curse
    May 4, 2011
    Latest News
    How IT and Marketing Teams Can Collaborate to Protect Patient Trust
    July 17, 2025
    How Health Choices and Legal Actions Intersect After an Injury
    July 17, 2025
    How communities and healthcare providers can address slip and fall injuries with legal awareness
    July 17, 2025
    Let Your Lawyer Handle the Work Before You Pay Medical Costs
    July 6, 2025
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: FDA Approves Oral Hepatitis C Virus Inhibitor
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Business > FDA Approves Oral Hepatitis C Virus Inhibitor
Business

FDA Approves Oral Hepatitis C Virus Inhibitor

BarbaraDuck
BarbaraDuck
Share
4 Min Read
SHARE

Hepatitis C is getting some good news as last month another drug went into clinical trials.  Also Merck will include VICTRELIS  in the patient assistance program through which eligible patients may be able to receive product free of charge.  This is the first  new treatment in 20 years.  In the trials more than 65% of the patients were cured, good news there.  The dosage is taken 3 times a day, a pill with meals. 

Hepatitis C is getting some good news as last month another drug went into clinical trials.  Also Merck will include VICTRELIS  in the patient assistance program through which eligible patients may be able to receive product free of charge.  This is the first  new treatment in 20 years.  In the trials more than 65% of the patients were cured, good news there.  The dosage is taken 3 times a day, a pill with meals. 

Boehringer Ingelheim Receives FDA Fast Track Approval for Hepatitis C Virus Treatment and Moves In To Phase 3 Trials

Hepatitis C is the primary cause of liver transplants un the US so sales are predicted to be pretty large with over 3 million in the US having the disease.  One of the benefits of the drug is that the length of time for a cure is less than current treatments.  BD 

WHITEHOUSE STATION, N.J., May 13, 2011 – Merck (NYSE:MRK) (known as MSD outside the United States and Canada) announced today that the U.S. Food and Drug Administration (FDA) has approved VICTRELIS™ (boceprevir), the company’s innovative new medicine for the treatment of chronic hepatitis C (CHC). VICTRELIS is approved for the treatment of CHC genotype 1 infection, in combination with peginterferon alfa and ribavirin, in adult patients (18 years of age and older) with compensated liver disease, including cirrhosis, who are previously untreated or who have failed previous interferon and ribavirin therapy.

VICTRELIS is the first in a new class of medicines known as hepatitis C virus (HCV) protease inhibitors approved for use in combination with peginterferon alfa and ribavirin, which is the current standard therapy, for the treatment of chronic hepatitis C.

“Compared to current standard therapy, VICTRELIS can significantly increase a patient’s chance of achieving undetectable levels of the virus, thereby obtaining an SVR. For many patients, VICTRELIS may allow for a shorter total duration of treatment.”

Merck will begin shipping VICTRELIS to pharmacies within a week so that patients will have access to this new medication as soon as possible. In addition, the company is expanding its support of public awareness and education programs for chronic hepatitis C. Resources include coupons to help eligible patients with their medication cost, reimbursement support to help patients understand their insurance coverage for VICTRELIS, and 24/7 nurse phone support.

http://www.merck.com/newsroom/news-release-archive/prescription-medicine-news/2011_0513.html?WT.svl=content&WT.pi=content+Views

More Read

Most Dangerous Occupations
Cleveland Clinic’s Latest Startup Tackles Hospital-Patient Communication and Scheduling
HIPAA Marketing Rule Guidance: Better Than Nothing
New Pure Hydrocodone Pain Killer Drug Being Developed
The Hidden Dangers of Working as a Health Care Professional

 

TAGGED:FDAhealth care businesshepatitis C
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5kFollowersLike
4.5kFollowersFollow
2.8kFollowersPin
136kSubscribersSubscribe

Latest News

holistic dental
Holistic Dentist Services Are Natural and Safe
Dental health Specialties
July 28, 2025
botox certification
Help Improve People’s Skin Health Via Botox Certification
Skin Specialties
July 22, 2025
Telemedicine Apps
Why Custom Telemedicine Apps Outperform Off‑the‑Shelf Solutions
Health
July 20, 2025
Grounded Healing: A Natural Ally for Sustainable Healthcare Systems
How IT and Marketing Teams Can Collaborate to Protect Patient Trust
Global Healthcare Policy & Law
July 17, 2025

You Might also Like

BusinessHealth Reform

HealthCare’s Need for Transparency Goes Far Beyond Pricing

December 10, 2012
Think Patients Are Bad At Communicating? Rethink Your Systems
Hospital Administration

Think Patients Are Bad At Communicating? Rethink Your Systems

January 17, 2019

Increase SEO Backlinks with Current Events

April 18, 2014

Person-Centered HealthCare: Patient-Centered Medical Homes Need to Become More “Patient-Centered”

June 14, 2013
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?